Pradaxa is a medicine licensed to reduce the risk of strokes and blood clots in people who have atrial fibrillation. This prescription medication works by preventing a certain protein in the body from forming blood clots. It comes in capsule form and is taken twice daily. Potential side effects include bleeding, abdominal (stomach) pain, and indigestion.
What Is Pradaxa?Pradaxa® (dabigatran etexilate mesylate) is a prescription medication approved to reduce the risk of stroke and blood clots in people with atrial fibrillation, a certain type of irregular heart rhythm (arrhythmia).
Approved by the United States Food and Drug Administration (FDA) in October 2010, Pradaxa is a long-awaited "blood thinner" that is easier to dose, requires less monitoring, and is more effective, compared to warfarin (Coumadin®, Jantoven®).